Alteration in Steroid Hormone and HER2/neu Receptor Status Following Neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Is There Any Hope?
- 1 January 2021
- journal article
- research article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 18 references indexed in Scilit:
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenCA: A Cancer Journal for Clinicians, 2015
- Triple negative breast cancer: an Indian perspectiveBreast Cancer: Targets and Therapy, 2015
- A study of triple negative breast cancer at a tertiary cancer care center in southern IndiaAnnals of Medical and Health Sciences Research, 2014
- Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North IndiaIndian Journal of Medical and Paediatric Oncology, 2013
- Triple Negative Status is a Poor Prognostic Indicator in Chinese Women with Breast Cancer: a Ten Year ReviewAsian Pacific Journal of Cancer Prevention, 2012
- Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian womenBreast Cancer: Targets and Therapy, 2011
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsLaboratory Investigation, 2011
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerJournal of Clinical Oncology, 2010
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic processCancer, 2002